Table 2.
Fistula closure and residual incontinence outcomes at discharge and 3 month follow-up, by site
| |
Site N (%) |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (n = 1354) | BG 1 (n = 85) | BG 2 (n = 50) | BG 3 (n = 5) | GU (n = 251) | NI 1 (n = 74) | NI 2 (n = 97) | NG 1 (n = 59) | NG 2 (n = 210) | NG 3 (n = 153) | UG 1 (n = 165) | UG 2 (n = 205) | |
| Urinary fistula closure at end of repair surgery (n = 1299) |
1245 (95.8) |
73 (88.0) |
45 (93.8) |
5 (100.0) |
231 (93.9) |
63 (95.5) |
89 (100) |
50 (94.3) |
195 (95.1) |
141 (94.6) |
155 (99.4) |
198 (99.5) |
| Urinary fistula closure at discharge (n = 1307) |
1104 (84.5) |
62 (75.6) |
34 (70.8) |
5 (100.0) |
204 (82.9) |
40 (59.7) |
72 (86.8) |
39 (72.2) |
189 (90.9) |
115 (76.5) |
141 (88.1) |
203 (100.0) |
| Urinary fistula closure at 3 month follow-up (n = 1274) |
1039 (81.6) |
52 (73.2) |
34 (70.8) |
3 (60.0) |
185 (75.2) |
40 (59.7) |
45 (66.2) |
37 (69.8) |
190 (91.4) |
117 (80.1) |
138 (86.8) |
198 (97.5) |
| Residual incontinence at discharge among women with urinary fistula (n = 1084) |
219 (20.2) |
19 (32.8) |
9 (27.3) |
2 (66.7) |
28 (13.7) |
3 (7.9) |
17 (24.3) |
12 (31.6) |
21 (11.2) |
35 (31.0) |
26 (18.6) |
47 23.62 |
| Residual incontinence at 3 months follow-up among women with urinary fistula (n = 1015) |
192 (18.9) |
9 (19.2) |
16 (47.1) |
3 (100.0) |
23 (12.5) |
4 (10.5) |
18 (40.9) |
8 (21.6) |
18 (9.8) |
34 (29.1) |
15 (10.9) |
44 (23.3) |
| RVF Closure at discharge (n = 47) |
44 (93.6) |
1 (100.0) |
2 (100.0) |
N/A |
9 (90.0) |
2 (100.0) |
4 (100.0) |
3 (100.0) |
5 (71.4) |
6 (100.0) |
5 (100.0) |
7 (100.0) |
| RVF Closure at 3 month follow-up (n = 43) | 36 (83.7) | 1 (100.0) | 1 (50.0) | N/A | 8 (80.0) | 3 (100.0) | 2 (100.0) | 3 (100.0) | 3 (75.0) | 3 (50.0) | 5 (100.0) | 7 (100.0) |
BG = Bangladesh, GU = Guinea, NI = Niger, NG = Nigeria, UG = Uganda.
N/A = not applicable.